The studies proposed in this project will enhance understanding of the cellular and extracellular factors that modulate the flux of cholesterol between cells and serum. This bi-directional movement of cholesterol is one of the major mechanisms by which cellular cholesterol homeostasis is maintained and the efflux of cholesterol from cells is the first step in the process by which excess peripheral cholesterol is returned to the liver for excretion.
Specific Aim 1 will use cyclodextrins to: 1) examine the kinetics and mechanism of transport of plasma membrane cholesterol to the endoplasmic reticulum, 2) probe the distribution of cholesterol in fast and slow kinetic pools within the plasma membrane, 3) examine the factors regulating the efflux of synthesized sterols and cholesterol derived from lysosomes and 4) relate the kinetic pools of plasma membrane cholesterol to physical lipid domains through the use of x-ray diffraction and NMR techniques.
Specific Aim 2 will focus on the lipoprotein-related factors that modulate bi-directional flux by: 1) expanding our studies showing that cyclodextrins can shuttle cholesterol between cells and lipoproteins and that phospholipid vesicle can function as cholesterol sinks to determine if there are natural shuttles and sinks in serum, 2) study how phospholipid enrichment changes bi-directional cholesterol flux and the sink/shuttle capacity of serum, 3) establish the roles of LCAT and CETP in the modulation of cholesterol efflux from fast and slow pools, and 4) investigate differences among sera in their sink/shuttle capacity and correlate these differences to serum parameters and the regulation of cell cholesterol flux. The information gained from these studies will enhance our understanding of the processes involved in cholesterol accumulation in the vessel wall and will provide insights on interventions to modulate the progression and regression of atherosclerotic plaque.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL022633-26
Application #
6642916
Study Section
Project Start
2002-07-01
Project End
2003-06-30
Budget Start
Budget End
Support Year
26
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Mcp Hahnemann University
Department
Type
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19102
Cuchel, Marina; Raper, Anna C; Conlon, Donna M et al. (2017) A novel approach to measuring macrophage-specific reverse cholesterol transport in vivo in humans. J Lipid Res 58:752-762
Nagao, Kohjiro; Hata, Mami; Tanaka, Kento et al. (2014) The roles of C-terminal helices of human apolipoprotein A-I in formation of high-density lipoprotein particles. Biochim Biophys Acta 1841:80-7
Weibel, Ginny L; Drazul-Schrader, Denise; Shivers, Debra K et al. (2014) Importance of evaluating cell cholesterol influx with efflux in determining the impact of human serum on cholesterol metabolism and atherosclerosis. Arterioscler Thromb Vasc Biol 34:17-25
Phillips, Michael C (2014) Molecular mechanisms of cellular cholesterol efflux. J Biol Chem 289:24020-9
Yang, Yanbo; Kuwano, Takashi; Lagor, William R et al. (2014) Lipidomic analyses of female mice lacking hepatic lipase and endothelial lipase indicate selective modulation of plasma lipid species. Lipids 49:505-15
Lagor, William R; Fields, David W; Bauer, Robert C et al. (2014) Genetic manipulation of the ApoF/Stat2 locus supports an important role for type I interferon signaling in atherosclerosis. Atherosclerosis 233:234-41
Chetty, Palaniappan Sevugan; Nguyen, David; Nickel, Margaret et al. (2013) Comparison of apoA-I helical structure and stability in discoidal and spherical HDL particles by HX and mass spectrometry. J Lipid Res 54:1589-97
Nguyen, David; Nickel, Margaret; Mizuguchi, Chiharu et al. (2013) Interactions of apolipoprotein A-I with high-density lipoprotein particles. Biochemistry 52:1963-72
Alexander, Eric T; Phillips, Michael C (2013) Influence of apolipoprotein A-I and apolipoprotein A-II availability on nascent HDL heterogeneity. J Lipid Res 54:3464-70
Patel, Parin J; Khera, Amit V; Wilensky, Robert L et al. (2013) Anti-oxidative and cholesterol efflux capacities of high-density lipoprotein are reduced in ischaemic cardiomyopathy. Eur J Heart Fail 15:1215-9

Showing the most recent 10 out of 336 publications